Skip to main content
. 2023 Oct 30;30(1):218–228. doi: 10.1038/s41591-023-02660-6

Extended Data Fig. 9. Kaplan–Meier curves of EFS by MPR status (PT) in patients with or without pathologic evidence of LN involvement.

Extended Data Fig. 9

a, Patients with LN involvement who received nivolumab plus chemotherapy and chemotherapy. b, Patients without LN involvement who received nivolumab plus chemotherapy and chemotherapy. CI denotes confidence interval; EFS, event-free survival; LN, lymph node; MPR, major pathologic response; PT, primary tumor.